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Introduction
ABCA12 is a member of the large superfamily of ATP-binding 
cassette (ABC) transporters,1 which bind and hydrolyze ATP to 
transport various molecules across limiting membranes or into 
vesicles.2 The ABCA subfamily members are thought to be lipid 
transporters.3 The ABC transporter A12 (ABCA12) is known 
to be a key molecule in keratinocyte lipid transport (Fig. 1).4-6 
ABCA12 is a keratinocyte transmembrane lipid transporter pro-
tein associated with the transport of lipids in lamellar granules 
to the apical surface of granular layer keratinocytes.4 This article 
reviews the importance of ABCA12 as a keratinocyte lipid trans-
porter in the context of keratinocyte differentiation and skin lipid 
barrier formation.
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ABCA12 is a member of the large superfamily of ATP-binding 
cassette (ABC) transporters, which bind and hydrolyze ATP 
to transport various molecules across limiting membranes or 
into vesicles. The ABCA subfamily members are thought to be 
lipid transporters. ABCA12 is a keratinocyte transmembrane 
lipid transporter protein associated with the transport of 
lipids in lamellar granules to the apical surface of granular 
layer keratinocytes. Extracellular lipids, including ceramide, 
are thought to be essential for skin barrier function. ABCA12 
mutations are known to underlie the three main types of 
autosomal recessive congenital ichthyoses: harlequin ichthyosis, 
lamellar ichthyosis and congenital ichthyosiform erythroderma. 
ABCA12 mutations lead to defective lipid transport via lamellar 
granules in the keratinocytes, resulting in malformation of the 
epidermal lipid barrier and ichthyosis phenotypes. Studies 
of ABCA12-deficient model mice indicate that lipid transport 
by ABCA12 is also indispensable for intact differentiation of 
keratinocytes.
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ABCA12 and Other ABCA Transporters
Several genetic diseases have been shown to be caused by muta-
tions in ABCA subfamily genes. The ABCA subfamily, of which 
the ABCA12 gene is a member, comprises 12 full transporters 
and one pseudogene (ABCA11) that are essential for lipid trans-
port and secretion.7 Three ABCA genes of the same subfamily as 
ABCA12 have been also implicated in the development of genetic 
diseases affecting cellular lipid transport. In the phylogenetic 
tree of ABCA subfamily proteins, ABCA3 is very close ABC12.1 
ABCA3 is known to aid lipid secretion from alveolar type II cells 
via lamellar granules,8 and an ABCA3 deficiency recently was 
reported to underlie a fatal lung surfactant deficiency in new-
borns,9 a condition that often leads to death shortly after birth.
Another important member of the ABCA subfamily is 
ABCA1. Mutations in the human ABCA1 gene underlie familial 
alpha-lipoprotein deficiency syndrome (Tangier disease), which 
suggests that ABCA1 is a major regulator of high-density lipo-
protein metabolism.10-12
ABCA2, ABCA3 and ABCA7 mRNA levels were reported 
to be upregulated after sustained cholesterol influx,13,14 suggest-
ing that ABCA transporters are involved in the transmembrane 
transport of endogenous lipids.15 From these facts, transporters in 
the ABCA subfamily are thought to be involved in the transmem-
brane transport of cholesterol.16-18 Interestingly, ABCA3, a mem-
ber of the same protein superfamily as ABCA12, functions in 
pulmonary surfactant lipid secretion through the production of 
similar lamellar-type granules within lung alveolar type II cells.8,9
The Role of ABCA12 in the Transport  
of Lipids into Lamellar Granules
Extracellular lipids, including ceramide, are thought to be essen-
tial for skin barrier function.19 Mutations in the ABCA12 gene 
(ABCA12) were reported to underlie the devastating phenotype 
seen in harlequin ichthyosis (HI) patients,4,20 the most severe 
keratinization disorder. ABCA12 mutations underlying HI 
are thought to have major disruptive defects on ABCA12 lipid 108  Dermato-Endocrinology  volume 3 issue 2
the upper spinous and granular cells (Fig. 2).5 Immunofluorescence 
labeling on ultrathin cryosections clearly reveals localization of 
ABCA12 and glucosylceramide. In immunofluorescence labeling 
under light microscopy, ABCA12 and glucosylceramide stain-
ing almost completely overlap within the granular layer kerati-
nocytes.5 Post-embedding immunoelectron microscopy reveals 
both ABCA12 and glucosylceramide in the LGs of the uppermost 
granular layer keratinocytes.5 Under immunoelectron microscopy 
using ultrathin cryosections, glucosylceramide labeling is seen with 
the lamellar structures in the LGs. ABCA12 immunogold labeling 
is observed on or close to the membrane surrounding LGs in the 
uppermost granular layer cells.5
We can hypothesize that ABCA12 is likely to be a membrane 
lipid transporter that functions in the transport of lipids from 
the trans-Golgi network to LGs at the keratinocyte periphery   
(Fig. 3).4,5 Recently, it was confirmed biochemically that ABCA12 
deficiency impairs glucosylceramide accumulation in lamel-
lar granules and that ABCA12 transports glucosylceramide to 
the inner side of lamellar granules.6 In addition, ceramide was 
reported to upregulate ABCA12 expression via PPAR delta-medi-
ated signaling pathway, providing a substrate-driven, feed-forward 
mechanism for regulation of this key lipid transporter.21 More 
recently, studies using Abca12-/- mice suggested that ABCA12 
plays an important role in the normal differentiation of epidermal 
keratinocytes.22
ABCA12 Mutations and Ichthyoses
ABCA12 mutations are known to underlie the three main types 
of autosomal recessive congenital ichthyoses: harlequin ichthyosis 
transporter function, resulting in the HI phenotype.4 We reported 
that ABCA12 is localized in lamellar granules (LGs) in the granu-
lar layer keratinocytes and might work in lipid transport through 
LGs to form the intercellular lipid layers in the stratum corneum.4 
We have analyzed the epidermal localization of ABCA12 in com-
parison with the localization of Golgi apparatus markers and 
LG-associated proteins together with transglutaminase 1, because 
LGs are thought to be a part of the continuous tubular network 
that originates from the Golgi apparatus and extends to the cell 
membrane.5 We employed antibodies to well-established marker 
molecules of each part of the Golgi apparatus-LG-cell membrane 
network, i.e., the GM130, anti-TGN-46 and anti-transgluta-
minase 1 antibodies (B.C1), as markers for cis-Golgi, trans-Golgi 
and cell membrane, respectively. Our results show that ABCA12 
localizes throughout the entire Golgi apparatus to LGs at the 
cell periphery, mainly in the granular layer keratinocytes. These 
results suggest that ABCA12 works in the transport of lipids from 
the Golgi apparatus to LGs in the granular layer cells.5 Double-
labeling immunofluorescence staining of cultured keratinocytes 
clearly indicates that ABCA12 is localized from the Golgi appa-
ratus (colocalized with cis-Golgi marker GM130 and trans-Golgi 
marker TGN-46) to the cell periphery (close to the plasma mem-
brane stained with transglutaminase 1). ABCA12 fails to colocal-
ize with TGase1, a cell membrane-bounding protein, both in vivo 
and in cultured keratinocytes and ABCA12 is thought to distribute 
only very sparsely on the cell membrane.5
In normal human epidermis, ABCA12 is expressed through-
out, but mainly in the upper spinous and granular layers.5 
Immunofluorecent double labeling reveals that the majority of 
ABCA12 colocalizes with glucosylceramide in the cytoplasm within 
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stratum corneum barrier function is not required. According 
to this theory, barrier defects cannot be involved directly in the 
pathogenesis of the HI phenotype, at least during the in utero 
fetal period. In light of this, disturbed keratinocyte differentia-
tion is speculated to play an important role in the pathogenesis 
of the HI phenotype. In fact, three-dimensional culture stud-
ies reveal that HI keratinocytes differentiate poorly according to 
morphologic criteria and show reduced expression of keratin 1 
and defective conversion from profilaggrin to filaggrin.32
In an ABCA12-ablated organotypic co-culture system, which 
is an in vitro model of HI skin, the expression of keratinocyte 
late differentiation-specific molecules is dysregulated.33 The 
expression of specific proteases associated with desquamation 
(kallikrein 5 and cathepsin D) is dramatically reduced in the 
ABCA12-ablated organotypic co-culture system.33 In this model 
system, ABCA12 ablation results in a premature terminal dif-
ferentiation phenotype.33 Furthermore, in mutant mice carrying 
a homozygous spontaneous missense mutation, loss of Abca12 
function leads to the premature differentiation of basal keratino-
cytes.34 In contrast, in our Abca12-/- HI model mice, immunoflu-
orescence and immunoblotting of Abca12-/- neonatal epidermis 
revealed defective profilaggrin/filaggrin conversion and reduced 
expression of the differentiation-specific molecules (loricrin, kal-
likrein 5 and transglutaminase 1), although their mRNA expres-
sion is upregulated.22 These data suggest that ABCA12 deficiency 
may lead to disturbances in keratinocyte differentiation during 
fetal development, resulting in an ichthyotic phenotype at birth. 
These observations suggest that ABCA12 deficiency might have 
global effects on keratinocyte differentiation, resulting in both 
impaired terminal differentiation and premature differentiation 
of the epidermis.
HI patients often die in the first week or two of life. However, 
those that survive beyond the neonatal period phenotypi-
cally improve within several weeks after birth. To clarify the 
mechanisms of phenotypic recovery, we studied grafted skin 
and keratinocytes from Abca12-disrupted (Abca12-/-) mice.22 
Abca12-/- skin grafts kept in a dry environment exhibited dra-
matic improvements in all the abnormalities seen in the model 
mice. Increased transepidermal water loss, a parameter of barrier 
defect, is remarkably decreased in grafted Abca12-/- skin. Ten-
passage sub-cultured Abca12-/- keratinocytes show restoration 
of intact ceramide distribution, differentiation-specific protein 
(HI), lamellar ichthyosis (LI) and congenital ichthy-
osiform erythroderma (CIE). Harlequin ichthyosis is 
the most severe ichthyosis subtype. Affected patients 
show plate-like scales over the whole body, severe 
eclabium and ectropion.
In 2010, a review of the literature was per-
formed to identify all known ABCA12 mutations in 
patients with ARCI and 56 ABCA12 mutations were 
described (online database: www.derm-hokudai.jp/
ABCA12/) in 66 unrelated families, including 48 
HI, 10 LI and 8 CIE families.23 Mutations have been 
reported among autosomal recessive congenital ich-
thyosis patients with African, European, Pakistani/
Indian and Japanese backgrounds in most parts of 
the world. Of the 56 mutations, 36% (20) are nonsense, 25% 
(14) are missense, 20% (11) comprise small deletions, 11% (6) 
are splice site, 5% (3) are large deletions and 4% (2) are insertion 
mutations. At least 62.5% (35) of all the reported mutations are 
predicted to result in truncated proteins. There is no apparent 
mutation hot spot in ABCA12, although mutations underlying 
the LI phenotype are clustered in the region of the first ATP-
binding cassette.24
In HI-affected epidermis, several morphologic abnormalities 
have been reported, including abnormal lamellar granules in the 
keratinocyte granular layer and a lack of extracellular lipid lamel-
lae within the stratum corneum.25-28 Lack of ABCA12 function 
subsequently leads to disruption of lamellar granule lipid trans-
port in the upper keratinizing epidermal cells, resulting in malfor-
mation of the intercellular lipid layers of the stratum corneum in 
HI.4 Cultured epidermal keratinocytes from an HI patient carry-
ing ABCA12 mutations demonstrate defective glucosylceramide 
transport, and this phenotype is recoverable by in vitro ABCA12 
corrective gene transfer.4 Intracytoplasmic glucosylceramide 
transport has been studied using cultured keratinocytes from a 
total of three patients harboring ABCA12 mutations. One patient 
was homozygous for the splice site mutation c.3295-2A>G4 
and another was compound heterozygous for p.Ser387Asn and 
p.Thr1387del.29 Only one heterozygous mutation, p.Ile1494Thr, 
was identified in the other patient.30 Cultured keratinocytes from 
all three patients showed apparently disturbed glucosylceramide 
transport, although this assay is not quantitative.
In addition, defective lamellar granule formation was observed 
in the skin of two CIE patients with ABCA12 mutations.30 
Electron microscopy revealed that, in the cytoplasm of granu-
lar layer keratinocytes, abnormal, defective lamellar granules are 
assembled with some normal-appearing lamellar granules.30
Formation of the intercellular lipid layers is essential for epi-
dermal barrier function. In ichthyotic skin with ABCA12 defi-
ciency, defective formation of the lipid layers is thought to result 
in a serious loss of barrier function and a likely extensive compen-
satory hyperkeratosis.31
One hypothetical pathomechanism for ABCA12 deficiency in 
autosomal recessive congenital ichthyosis is explained by the “dif-
ferentiation defect theory,” which is derived from the clinical fea-
tures of HI patients. Fetuses affected with HI start developing the 
ichthyotic phenotype while they are in the amniotic fluid, where 
Figure 2. immunofluorescence labeling using ultrathin cryosections as substrates 
reveal that glucosylceramide (green) and ABCA12 (red) overlap in the granular layers 
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Another group independently developed Abca12-/- mice and these 
also had the clinical features of HI.37
A study in one Abca12-disrupted HI model mouse indicates 
that a lack of desquamation of skin cells, rather than enhanced 
proliferation of basal-layer keratinocytes accounts for the five-
fold thickening of the Abca12-/- stratum corneum determined by 
in vivo skin proliferation measurements.37 It was suggested that 
this lack of desquamation is associated with a profound reduction 
in skin linoleic esters of long-chain omega-hydroxyceramides and 
a corresponding increase in their glucosylceramide precursors. 
Omega-hydroxyceramides are required for correct skin barrier 
function, and these results from HI model mice establish that 
ABCA12 activity is required for the generation of the long-chain 
ceramide esters that are essential for the development of normal 
skin structure and function.37
In addition, a mouse strain carrying a homozygous spontane-
ous missense mutation was reported to show skin manifestations 
similar to ichthyosis.34 Lipid analysis of Abca12 mutant epider-
mis revealed defects in lipid homeostasis, suggesting that Abca12 
plays a crucial role in maintaining lipid balance in the skin.34 The 
cells from the Abca12 mutant mouse have severely impaired lipid 
efflux and intracellular accumulation of neutral lipids.34 Abca12 
was also demonstrated as a mediator of Abca1-regulated cellular 
cholesterol efflux.34 Injection of a morpholino designed to target 
a splice site at the exon 4/intron 4 junction to block Abca12 pre-
mRNA processing induced altered skin surface contours, disor-
ganization of the melanophore distribution, pericardial edema 
expression and profilaggrin/filaggrin conversion, which are 
defective in the primary-culture.22 These observations suggest 
that, during maturation, Abca12-/- epidermal keratinocytes regain 
normal differentiation processes, although the exact mechanisms 
of this restoration remain unknown.22
ABCA12-deficient Animal Models
Recently, bioengineered disease models were established to inves-
tigate the ichthyotic pathomechanisms that result from defec-
tive ABCA12 function and to aid the development of innovative 
treatments for ichthyosis with ABCA12 deficiency.
We transplanted cultured keratinocytes from patients with HI 
and succeeded in reproducing HI skin lesions in immunodefi-
cient mice.35 These reconstituted HI lesions show similar changes 
to those observed in HI patients’ skin. In addition, we gener-
ated Abca12-disrupted (Abca12-/-) mice that closely reproduced 
the human HI phenotype, showing marked hyperkeratosis with 
eclabium and skin fissures.36 Lamellar granule abnormalities and 
defective ceramide distribution were remarkable in the epider-
mis. Skin permeability assays of Abca12-/- mouse fetuses revealed 
severe skin barrier dysfunction after the initiation of keratini-
zation. Surprisingly, the Abca12-/- mice also demonstrated lung 
alveolar collapse immediately after birth. Lamellar bodies in 
alveolar type II cells from Abca12-/- mice lack normal lamellar 
structures.36 The level of surfactant protein B, an essential com-
ponent of alveolar surfactant, is reduced in the Abca12-/- mice.36 
Figure 3. Scheme of ABCA12 distribution from the cis-Golgi, trans-Golgi network to lamellar granules in the upper spinous and granular layer kerati-
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works in the transport of lipids into the trans-Golgi network and 
lamellar granules, to accumulate lipids that are essential to skin 
barrier formation. Consequently, the lipids packed in lamellar 
granules are secreted to the extracellular space to form intercel-
lular lipid layers in the stratum cornuem, which is important   
for skin barrier function (Fig. 4). In addition, model   
mouse studies indicate that lipid transport by ABCA12 is   
indispensable for intact differentiation of keratinocytes.   
To elucidate the mechanisms of ABCA12 in keratinocyte   
differentiation/proliferation, further accumulation of data is 
needed.
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Conclusion
ABCA12 is apparently localized in the membrane of the trans-
Golgi network and lamellar granules in the upper epidermis, 
mainly in the uppermost spinous and granular layer cells. Our 
own studies and a review of the literature suggest that ABCA12 
Figure 4. Physiological role(s) of ABCA12 in lipid trafficking of epidermal keratinocytes and the model of pathogenetic mechanisms in ichthyosis 
phenotypes caused by ABCA12 deficiency. (A) Model of how ABCA12 transports lipids in epidermal keratinocytes. (B) Model of how loss of ABCA12 
function leads to lipid abnormality and lipid barrier malformation in the upper epidermis. (C) it is hypothesized that the combination of lipid barrier 
defects and disturbed keratinocyte differentiation cause hyperkeratosis and the ichthyosis phenotype (derived from ref. 20).112  Dermato-Endocrinology  volume 3 issue 2
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